Fluconazole is an antifungal medication used to treat and prevent a range of fungal infections, from common vaginal yeast infections to serious conditions like fungal meningitis. It works by disrupting the membranes of fungal cells, making it effective against most Candida species and certain other fungi. It’s available as a tablet, liquid, or IV infusion and is one of the most widely prescribed antifungals in the world.
How Fluconazole Works
Fungal cells depend on a substance called ergosterol to keep their cell membranes stable and intact. Fluconazole blocks the enzyme responsible for producing ergosterol, which weakens the membrane and makes it increasingly permeable. Without a functional membrane, the fungal cell can’t maintain its internal environment and dies. This mechanism is specific to fungi, so fluconazole doesn’t damage human cells in the same way.
Vaginal Yeast Infections
The most common reason people take fluconazole is for vaginal yeast infections caused by Candida. For uncomplicated cases, a single 150 mg oral dose is the standard treatment recommended by global guidelines. In a clinical study, about 82% of patients were clinically cured by day 28, and nearly 96% showed cure or improvement. Most people notice symptom relief within one to three days, though the infection may take up to a week to fully clear.
For recurrent yeast infections (four or more episodes per year), a longer course is typically needed. This often involves an initial dose followed by weekly doses for several months to prevent the infection from returning.
Oral and Esophageal Thrush
Fluconazole is a first-line treatment for oral thrush (oropharyngeal candidiasis), the white patches caused by Candida overgrowth in the mouth and throat. This is particularly common in people with weakened immune systems, including those living with HIV, people receiving chemotherapy, and organ transplant recipients. Treatment typically lasts one to two weeks.
When the infection spreads deeper into the esophagus, causing pain with swallowing, fluconazole is used at higher doses for two to three weeks. Esophageal candidiasis is more serious and almost always occurs in people with significant immune suppression.
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening fungal infection of the membranes surrounding the brain and spinal cord. It primarily affects people with advanced HIV. While stronger antifungal drugs are used for the initial treatment phase, fluconazole plays a critical role in maintenance therapy afterward. HIV treatment guidelines recommend 200 mg daily for at least one year to prevent relapse. This long maintenance period is necessary because the fungus can persist in the body and reactivate if treatment stops too soon.
Prevention in Transplant Patients
People undergoing bone marrow transplants face a high risk of invasive Candida infections because chemotherapy and radiation severely suppress the immune system. Fluconazole is approved for prophylactic use in these patients, taken daily during the period of greatest vulnerability to reduce the chance of developing a serious bloodstream or organ infection.
Other Fungal Infections
Beyond its primary approved uses, fluconazole has shown effectiveness against several other types of Candida infections. These include urinary tract infections caused by Candida, fungal infections of the abdominal cavity (peritonitis), and systemic infections where Candida enters the bloodstream (candidemia) or spreads to multiple organs. These are serious conditions that typically occur in hospitalized patients and require higher doses over longer treatment courses.
Use in Children
Fluconazole is used in children for many of the same infections as in adults. Dosing is based on body weight rather than fixed amounts. For oral thrush and superficial Candida infections, children generally receive 6 mg per kilogram of body weight daily. For bloodstream infections or other serious systemic infections, the dose increases to 12 mg per kilogram daily. In overweight or obese children, dosing is based on total body weight. Post-pubertal females receive the same single 150 mg dose as adults for vaginal yeast infections.
Common Side Effects
Fluconazole is generally well tolerated, especially at lower doses and shorter courses. The most common side effects include nausea, headache, stomach pain, and diarrhea. These tend to be mild and resolve on their own.
Liver stress is the most significant safety concern, particularly during longer treatment courses. In a large meta-analysis, about 9% of patients on antifungal therapy showed some degree of elevated liver enzymes, though only 0.7% had liver changes serious enough to require stopping treatment. Among antifungal drugs overall, fluconazole had one of the better liver safety profiles. Patients on extended courses are typically monitored with blood tests to catch any liver problems early.
Drug Interactions to Know About
Fluconazole is a strong inhibitor of one liver enzyme pathway and a moderate inhibitor of two others involved in processing medications. This means it can significantly raise blood levels of other drugs your body would normally break down through those pathways, potentially increasing their side effects or toxicity.
Medications that commonly interact with fluconazole include certain blood thinners, some cholesterol-lowering drugs, specific anti-seizure medications, certain blood pressure medications, and some sedatives. If you’re prescribed fluconazole and take other medications regularly, your prescriber will check for interactions and may adjust doses accordingly.
Pregnancy Considerations
A single 150 mg dose for a vaginal yeast infection has not been linked to birth defects in available human data. However, prolonged use of high doses (400 to 800 mg daily) during the first trimester has been associated with a rare but distinct pattern of birth defects. Case reports describe skeletal abnormalities, cleft palate, abnormal skull development, and congenital heart defects in infants exposed to chronic high-dose fluconazole early in pregnancy.
The FDA changed the pregnancy classification for long-term, high-dose fluconazole to category D, meaning there is positive evidence of human fetal risk. The single low-dose use for yeast infections remains in a lower risk category. For pregnant people who need treatment for serious fungal infections, the decision involves weighing the severity of the infection against the potential risks to the fetus.
Fungal Resistance
Not all fungi respond to fluconazole. Candida krusei is inherently resistant, and Candida glabrata has naturally low susceptibility to the drug and can rapidly develop full resistance during treatment. This is one reason healthcare providers may order a culture to identify the specific fungal species before starting therapy, especially in patients with recurrent or treatment-resistant infections. The growing prevalence of resistant Candida species is an ongoing concern that sometimes requires switching to a different class of antifungal.